Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of isoniazid with lopinavir/ritonavir, nevirapine, or efavirenz in South African adults with HIV infection
PACTR201206000391313Recruiting
- Sponsor
- University of Cape Town
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of isoniazid, lopinavir + ritonavir, nevirapine and efavirenz in human immunodeficiency virus infection (HIV) and Tuberculosis (TB) (3 cohorts), sponsored by University of Cape Town. Primary endpoint: Pharmacokinetics of lopinavir. Started Jun 2012; status: recruiting.
02
Drugs
isoniazidlopinavir + ritonavirnevirapineefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)Tuberculosis (TB)
Beyond the preview
Go deeper on PACTR201206000391313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201206000391313.